Convection-enhanced delivery of liposomal doxorubicin in intracranial brain tumor xenografts
Convection-enhanced delivery of liposomal doxorubicin in intracranial brain tumor xenografts
复制标题
颅内脑肿瘤异种移植物中脂质体阿霉素的对流增强递送
DOI:
10.1007/s11523-006-0011-8
复制
发表时间:
2006
影响因子:
5.4
通讯作者:
K. Bankiewicz
中科院分区:
文献类型:
--
作者:
Y. Yamashita;R. Saito;M. Krauze;T. Kawaguchi;C. Noble;D. Drummond;D. Kirpotin;John W. Park;M. Berger;K. Bankiewicz
We previously reported that convection-enhanced delivery (CED) of liposomes into brain tissue and intracranial brain tumor xenografts produced robust tissue distribution that can be detected by magnetic resonance imaging. Considering image-guided CED of therapeutic liposomes as a promising strategy for the treatment of brain tumors, we evaluated the efficacy of pegylated liposomal doxorubicin delivered by CED in an animal model. Distribution, toxicity, and efficacy of pegylated liposomal doxorubicin after CED were evaluated in a U251MG human glioblastoma intracranial xenograft model. CED of pegylated liposomal doxorubicin achieved good distribution in brain tumor tissue and surrounding normal brain tissue. Distribution was not affected by the particle concentration of pegylated liposomal doxorubicin, but tissue toxicity increased at higher concentrations. CED of pegylated liposomal doxorubicin, at a dose not toxic to normal rat brain (0.1 mg/ml doxorubicin), was significantly more efficacious than systemic administration of pegylated liposomal doxorubicin at the maximum tolerated dose. CED of pegylated liposomal doxorubicin resulted in improved survival compared to CED of free doxorubicin at the same dose. Outcomes of this study suggest that CED of liposomal drugs is a promising approach for the treatment of glioblastoma.
影响因子:
4.8
作者:
M. Kaiser;A. Parsa;R. Fine;Jonathan S. Hall;I. Chakrabarti;J. Bruce
通讯作者:
J. Bruce
影响因子:
4.1
作者:
Degen, JW;Walbridge, S;Lonser, RR
通讯作者:
Lonser, RR
影响因子:
2
作者:
A. Kolchinsky;Roninson Ib
通讯作者:
A. Kolchinsky;Roninson Ib